Literature DB >> 1318546

A structural assessment of the apo[a] protein of human lipoprotein[a].

J Guevara1, R D Knapp, S Honda, S R Northup, J D Morrisett.   

Abstract

Apolipoprotein[a], the highly glycosylated, hydrophilic apoprotein of lipoprotein[a] (Lp[a]), is generally considered to be a multimeric homologue of plasminogen, and to exhibit atherogenic/thrombogenic properties. The cDNA-inferred amino acid sequence of apo[a] indicates that apo[a], like plasminogen and some zymogens, is composed of a kringle domain and a serine protease domain. To gain insight into possible positive functions of Lp[a], we have examined the apo[a] primary structure by comparing its sequence with those of other proteins involved in coagulation and fibrinolysis, and its secondary structure by using a combination of structure prediction algorithms. The kringle domain encompasses 11 distinct types of repeating units, 9 of which contain 114 residues. These units, called kringles, are similar but not identical to each other or to PGK4. Each apo[a] kringle type was compared with kringles which have been shown to bind lysine and fibrin, and with bovine prothrombin kringle 1. Apo[a] kringles are linked by serine/threonine- and proline-rich stretches similar to regions in immunoglobulins, adhesion molecules, glycoprotein Ib-alpha subunit, and kininogen. In comparing the protease domains of apo[a] and plasmin, apo[a] contains a region between positions 4470 and 4492 where 8 substitutions, 9 deletions, and 1 insertion are apparent. Our analysis suggests that apo[a] kringle-type 10 has a high probability of binding to lysine in the same way as PGK4. In the only human apo[a] polymorph sequenced to date, position 4308 is occupied by serine, whereas the homologous position in plasmin is occupied by arginine and is an important site for proteolytic cleavage and activation. An alternative site for the proteolytic activation of human apo[a] is proposed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318546     DOI: 10.1002/prot.340120212

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  11 in total

Review 1.  Lipoprotein (a) measurements for clinical application.

Authors:  Santica M Marcovina; John J Albers
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

2.  Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay.

Authors:  R W Evans; S S Sankey; B A Hauth; K Sutton-Tyrrell; M I Kamboh; L H Kuller
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

Review 3.  The role of lipoprotein[a] in atherosclerosis.

Authors:  J D Morrisett
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

4.  Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].

Authors:  J Guevara; J Spurlino; A Y Jan; C Y Yang; A Tulinsky; B V Prasad; J W Gaubatz; J D Morrisett
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

Review 5.  Lipoprotein (a): When to Measure and How to Treat?

Authors:  David Rhainds; Mathieu R Brodeur; Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2021-07-08       Impact factor: 5.113

6.  Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model.

Authors:  Ho-Jeong Lee; Hyun-Kyung Yu; John N Papadopoulos; Seung Wook Kim; Junqin He; Yong-Keun Park; Yeup Yoon; Jang-Seong Kim; Sun Jin Kim
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

Review 7.  Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.

Authors:  Anjali Manocha; L M Srivastava
Journal:  Indian J Clin Biochem       Date:  2015-03-04

8.  Serum Lipoprotein (a) Levels in Black South African Type 2 Diabetes Mellitus Patients.

Authors:  Jim Joseph; Farzana Ganjifrockwala; Grace George
Journal:  Oxid Med Cell Longev       Date:  2016-10-19       Impact factor: 6.543

9.  The rs10455872-G allele of the LPA gene is associated with high lipoprotein(a) levels and increased aortic valve calcium in a Mexican adult population.

Authors:  Guillermo Cardoso-Saldaña; José Manuel Fragoso; Shamar Lale-Farjat; Margarita Torres-Tamayo; Carlos Posadas-Romero; Gilberto Vargas-Alarcón; Rosalinda Posadas-Sánchez
Journal:  Genet Mol Biol       Date:  2019-11-14       Impact factor: 1.771

10.  Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.

Authors:  Johanna F Schachtl-Riess; Azin Kheirkhah; Rebecca Grüneis; Silvia Di Maio; Sebastian Schoenherr; Gertraud Streiter; Jamie Lee Losso; Bernhard Paulweber; Kai-Uwe Eckardt; Anna Köttgen; Claudia Lamina; Florian Kronenberg; Stefan Coassin
Journal:  J Am Coll Cardiol       Date:  2021-08-03       Impact factor: 27.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.